Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (19723)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 7, 2014 (publication date) through Dec 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ansaldi F, Orsi A, Sticchi L, Bruzzone B, Icardi G. Hepatitis C virus in the new era: Perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy. World J Gastroenterol 2014; 20(29): 9633-9652 [PMID: 25110404 DOI: 10.3748/wjg.v20.i29.9633] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v20/i29/9633.htm |
| Number | Citing Articles |
| 1 |
M. J. Nielsen, M. A. Karsdal, K. Kazankov, H. Grønbaek, A. Krag, D. J. Leeming, D. Schuppan, J. George. Fibrosis is not just fibrosis - basement membrane modelling and collagen metabolism differs between hepatitis B- and C-induced injury. Alimentary Pharmacology & Therapeutics 2016; 44(11-12): 1242 doi: 10.1111/apt.13819
|
| 2 |
Simona Georgescu, Mircea Tampa, Madalina Mitran, Cristina Mitran, Maria Sarbu, Ilinca Nicolae, Clara Matei, Constantin Caruntu, Monica Neagu, Mircea Popa. Potential pathogenic mechanisms involved in the association between lichen planus and hepatitis C virus infection (Review). Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6987
|
| 3 |
Cecilia Trucchi, Andrea Orsi, Cristiano Alicino, Laura Sticchi, Giancarlo Icardi, Filippo Ansaldi. State of the Art, Unresolved Issues, and Future Research Directions in the Fight against Hepatitis C Virus: Perspectives for Screening, Diagnostics of Resistances, and Immunization. Journal of Immunology Research 2016; 2016: 1 doi: 10.1155/2016/1412840
|
| 4 |
Mohamed AbdElrahman, Marwa K. Ibrahim, Salwa Tawfik, Dalia Omran, Mahmoud M. Bendary, Soha Osama Hassanin, Hassan Elbatae. The relation between SNPs in the NME1 gene and response to sofosbuvir in Egyptian patients with chronic HCV. Beni-Suef University Journal of Basic and Applied Sciences 2023; 12(1) doi: 10.1186/s43088-022-00337-6
|
| 5 |
Syed‐Mohammed Jafri, Stuart C. Gordon. Epidemiology of Hepatitis C. Clinical Liver Disease 2018; 12(5): 140 doi: 10.1002/cld.783
|
| 6 |
Fiona McPhee, Yoshiyuki Suzuki, Joji Toyota, Yoshiyasu Karino, Kasuaki Chayama, Yoshiiku Kawakami, Min Lung Yu, Sang Hoon Ahn, Hiroki Ishikawa, Rafia Bhore, Nannan Zhou, Dennis Hernandez, Patricia Mendez, Hiromitsu Kumada. High Sustained Virologic Response to Daclatasvir Plus Asunaprevir in Elderly and Cirrhotic Patients with Hepatitis C Virus Genotype 1b Without Baseline NS5A Polymorphisms. Advances in Therapy 2015; 32(7): 637 doi: 10.1007/s12325-015-0221-5
|
| 7 |
Giovanni Faria SILVA, Vanessa Gutierrez de ANDRADE, Alecsandro MOREIRA. WAITING DAAS LIST MORTALITY IMPACT IN HCV CIRRHOTIC PATIENTS. Arquivos de Gastroenterologia 2018; 55(4): 343 doi: 10.1590/s0004-2803.201800000-76
|
| 8 |
Charlie Bernier, Coralie Goetz, Eric Jubinville, Julie Jean. The New Face of Berries: A Review of Their Antiviral Proprieties. Foods 2021; 11(1): 102 doi: 10.3390/foods11010102
|
| 9 |
Anna Davydova, Maria Vorobjeva, Dmitrii Pyshnyi, Sidney Altman, Valentin Vlassov, Alya Venyaminova. Aptamers against pathogenic microorganisms. Critical Reviews in Microbiology 2016; 42(6): 847 doi: 10.3109/1040841X.2015.1070115
|
| 10 |
Xhevat Jakupi, Jana Mlakar, Maja M. Lunar, Katja Seme, Ibrahim Rudhani, Lul Raka, Adriana Vince, Mario Poljak. A very high prevalence of hepatitis C virus infection among patients undergoing hemodialysis in Kosovo: a nationwide study. BMC Nephrology 2018; 19(1) doi: 10.1186/s12882-018-1100-5
|
| 11 |
Fumitaka Suzuki, Naoya Hatanaka, Etsuya Bando, Koji Nakamura, Akira Komoto. Safety and effectiveness of daclatasvir and asunaprevir dual therapy in patients with genotype 1 chronic hepatitis C: results from postmarketing surveillance in Japan. Hepatology International 2018; 12(3): 244 doi: 10.1007/s12072-018-9872-z
|
| 12 |
Tijana Radonjić, Marija Dukić, Igor Jovanović, Marija Zdravković, Olga Mandić, Višeslav Popadić, Maja Popović, Novica Nikolić, Slobodan Klašnja, Anica Divac, Zoran Todorović, Marija Branković. Aging of Liver in Its Different Diseases. International Journal of Molecular Sciences 2022; 23(21): 13085 doi: 10.3390/ijms232113085
|
| 13 |
Suhail H Al-Amad. Willingness of dentists in the United Arab Emirates to perform restorative and surgical treatments for patients infected with hepatitis C. Archives of Public Health 2021; 79(1) doi: 10.1186/s13690-021-00756-4
|
| 14 |
Marian-Sorin Popescu, Andrei Ioan Drocas, Andrei Osman, Dan-Mihai Firu, Vlad Pădureanu, Cristina Maria Mărginean, Daniel-Cristian Pîrvu, Radu Mitruț, Dragoș Nicolae Mărgăritescu, Antonia Radu, Daniela Calina, Anca Oana Docea, Paul Mitruț. The Extent of Insulin Resistance in Patients That Cleared Viral Hepatitis C Infection and the Role of Pre-Existent Type 2 Diabetes Mellitus: A Meta-Analysis. Reports 2022; 5(4): 42 doi: 10.3390/reports5040042
|
| 15 |
Linh Thuy Nguyen, Emma Gray, Jonathan Dean, Michael Carr, Jeff Connell, Cillian De Gascun, Lan Anh Nguyen, Aisling O'Leary, Colm Bergin, William Hall, Suzanne Norris. Baseline Prevalence and Emergence of Protease Inhibitor Resistance Mutations following Treatment in Chronic HCV Genotype-1-Infected Individuals. Antiviral Therapy 2015; 20(8): 865 doi: 10.3851/IMP2964
|
| 16 |
Kerstin Wissel, Pietro Vernazza, Stefan Kuster, Katharina Hensel-Koch, Andrea Bregenzer. Hepatitis C prevalence and cascade of care among patients in the decentralised opioid agonist therapy programme of the canton of St Gallen, Switzerland: a cross-sectional study. Swiss Medical Weekly 2024; 154(2): 3352 doi: 10.57187/s.3352
|
| 17 |
Helen Hampton, ElizabethS Farrington, Adam Ellery, Mary McKenna, William Stableforth, Hyder Hussaini. Community hepatitis C treatment in Cornwall: a model to improve care. Gastrointestinal Nursing 2015; 13(Sup5): S17 doi: 10.12968/gasn.2015.13.Sup5.S17
|
| 18 |
Zobair M. Younossi, Maria Stepanova, Nezam Afdhal, Kris V. Kowdley, Stefan Zeuzem, Linda Henry, Sharon L. Hunt, Patrick Marcellin. Improvement of health-related quality of life and work productivity in chronic hepatitis C patients with early and advanced fibrosis treated with ledipasvir and sofosbuvir. Journal of Hepatology 2015; 63(2): 337 doi: 10.1016/j.jhep.2015.03.014
|
| 19 |
Anika Jabin, Mohammad Fahim Uddin, Salauddin Al Azad, Ashfaque Rahman, Fawzia Tabassum, Pritthy Sarker, A K M Helal Morshed, Samiur Rahman, Fatima Fairuz Raisa, Musfiqur Rahman Sakib, Abeer Hasan Olive, Tabassum Islam, Ramisha Tahsin, Shahlaa Zernaz Ahmed, Partha Biswas, Mst. Umme Habiba, Mahbuba Siddiquy, Maryam Jafary. Target-specificity of different amyrin subunits in impeding HCV influx mechanism inside the human cells considering the quantum tunnel profiles and molecular strings of the CD81 receptor: a combined in silico and in vivo study. In Silico Pharmacology 2023; 11(1) doi: 10.1007/s40203-023-00144-6
|
| 20 |
Renee Pozza, Catherine Hill, Anna Marie Hefner, Beth Vawter, Tarek Hassanein. Hepatitis C infection. The Nurse Practitioner 2017; 42(5): 14 doi: 10.1097/01.NPR.0000515423.38284.28
|
| 21 |
Riccardo Scotto, Antonio Riccardo Buonomo, Nicola Schiano Moriello, Alberto Enrico Maraolo, Emanuela Zappulo, Biagio Pinchera, Ivan Gentile, Guglielmo Borgia. Real-World Efficacy and Safety of Pangenotypic Direct-Acting Antivirals Against Hepatitis C Virus Infection. Reviews on Recent Clinical Trials 2019; 14(3): 173 doi: 10.2174/1574887114666190306154650
|
| 22 |
Sylwia Osuch, Karin J. Metzner, Kamila Caraballo Cortés. Reversal of T Cell Exhaustion in Chronic HCV Infection. Viruses 2020; 12(8): 799 doi: 10.3390/v12080799
|
| 23 |
Michelle Pardee. Diagnosis and Management of Hepatitis B and C. Nursing Clinics of North America 2019; 54(2): 277 doi: 10.1016/j.cnur.2019.02.004
|
| 24 |
Antoni Sicras-Mainar, Ruth Navarro-Artieda, Marc Sáez-Zafra. Comorbilidad, medicación concomitante, uso de recursos y costes sanitarios asociados a los pacientes portadores del virus de la hepatitis C crónica en España. Gastroenterología y Hepatología 2018; 41(4): 234 doi: 10.1016/j.gastrohep.2017.11.008
|
| 25 |
Johnathan D. Guest, Ruixue Wang, Khadija H. Elkholy, Andrezza Chagas, Kinlin L. Chao, Thomas E. Cleveland, Young Chang Kim, Zhen-Yong Keck, Alexander Marin, Abdul S. Yunus, Roy A. Mariuzza, Alexander K. Andrianov, Eric A. Toth, Steven K. H. Foung, Brian G. Pierce, Thomas R. Fuerst. Design of a native-like secreted form of the hepatitis C virus E1E2 heterodimer. Proceedings of the National Academy of Sciences 2021; 118(3) doi: 10.1073/pnas.2015149118
|
| 26 |
Waqar Al-Kubaisy, Suzanna Daud, Mustafa Waseem Al-Kubaisi, Omar Waseem Al-Kubaisi, Nik Nairan Abdullah. Maternal hepatitis C (HCV) infection and Anti-D immunoglobulin therapy: study testing antibodies, RNA and Genotype of HCV in Baghdad. The Journal of Maternal-Fetal & Neonatal Medicine 2019; 32(20): 3464 doi: 10.1080/14767058.2018.1465557
|
| 27 |
Arthi Venkatesan, Febin Prabhu Dass J.. Review on chemogenomic approaches towards hepatitis C viral targets. Journal of Cellular Biochemistry 2019; 120(8): 12167 doi: 10.1002/jcb.28581
|
| 28 |
Shereen Abou Bakr Saleh, Khaled Mohamed Abdelwahab, Asmaa Mady Mady, Ghada Abdelrahman Mohamed. The impact of achieving a sustained virological response with direct-acting antivirals on serum autotaxin levels in chronic hepatitis C patients. Egyptian Liver Journal 2020; 10(1) doi: 10.1186/s43066-020-00060-w
|
| 29 |
Miguel Angel Martinez, Sandra Franco. Therapy Implications of Hepatitis C Virus Genetic Diversity. Viruses 2020; 13(1): 41 doi: 10.3390/v13010041
|
| 30 |
Lenche Kostadinova, Carey L. Shive, Chelsey Judge, Elizabeth Zebrowski, Anita Compan, Kelsey Rife, Amy Hirsch, Yngve Falck-Ytter, Daniela M. Schlatzer, Xiaolin Li, Mark R. Chance, Benigno Rodriguez, Daniel L Popkin, Donald D. Anthony. During Hepatitis C Virus (HCV) Infection and HCV-HIV Coinfection, an Elevated Plasma Level of Autotaxin Is Associated With Lysophosphatidic Acid and Markers of Immune Activation That Normalize During Interferon-Free HCV Therapy. Journal of Infectious Diseases 2016; 214(9): 1438 doi: 10.1093/infdis/jiw372
|
| 31 |
Allison E. Wang, Eric Hsieh, Barbara J. Turner, Norah Terrault. Integrating Management of Hepatitis C Infection into Primary Care: the Key to Hepatitis C Elimination Efforts. Journal of General Internal Medicine 2022; 37(13): 3435 doi: 10.1007/s11606-022-07628-9
|
| 32 |
Miguel Angel Martinez, Sandra Franco. Antiviral Drug Discovery and Development. Advances in Experimental Medicine and Biology 2021; 1322: 139 doi: 10.1007/978-981-16-0267-2_6
|
| 33 |
Germana Grassi, Giorgia Di Caprio, Gian Maria Fimia, Giuseppe Ippolito, Marco Tripodi, Tonino Alonzi. Hepatitis C virus relies on lipoproteins for its life cycle. World Journal of Gastroenterology 2016; 22(6): 1953-1965 doi: 10.3748/wjg.v22.i6.1953
|
| 34 |
Lenche Kostadinova, Carey L Shive, Donald D Anthony. Elevated Autotaxin and LPA Levels during Chronic Viral Hepatitis and Hepatocellular Carcinoma Associate with Systemic Immune Activation. Cancers 2019; 11(12): 1867 doi: 10.3390/cancers11121867
|
| 35 |
Antoni Sicras-Mainar, Ruth Navarro-Artieda, Marc Sáez-Zafra. Comorbidity, concomitant medication, use of resources and healthcare costs associated with chronic hepatitis C virus carriers in Spain. Gastroenterología y Hepatología (English Edition) 2018; 41(4): 234 doi: 10.1016/j.gastre.2018.04.015
|
| 36 |
Ping Chen, Yang Zheng, Yubo Cai, Pengfei Zou, Nan Li, Conggao Peng, Hainv Gao, Jimin Liu, Yongping Chen, Zhaowei Tong, Lanjuan Li. Prevalence of Hepatitis C Virus Infection in a Surgical Population of Southeast China: A Large-Scale Multicenter Study. Canadian Journal of Gastroenterology and Hepatology 2020; 2020: 1 doi: 10.1155/2020/8219536
|
| 37 |
Irini D. Batsis, Paul Wasuwanich, Wikrom W. Karnsakul. The management of hepatitis B and hepatitis C in children. Minerva Pediatrica 2018; 71(1) doi: 10.23736/S0026-4946.18.05410-5
|
| 38 |
Francesco Lapi, Alice Capogrosso Sansone, Stefania Mantarro, Monica Simonetti, Marco Tuccori, Corrado Blandizzi, Alessandro Rossi, Giampaolo Corti, Alessandro Bartoloni, Alfonso Bellia, Leonardo Baiocchi, Iacopo Cricelli, Claudio Cricelli. Hepatitis C virus infection: opportunities for an earlier detection in primary care. European Journal of Gastroenterology & Hepatology 2017; 29(3): 271 doi: 10.1097/MEG.0000000000000785
|
| 39 |
Naomi Lange, Jean-François Dufour. Changing Epidemiology of HCC: How to Screen and Identify Patients at Risk?. Digestive Diseases and Sciences 2019; 64(4): 903 doi: 10.1007/s10620-019-05515-8
|
| 40 |
Alexander M. Sy, Christopher B. O’Brien. Liver Failure. 2020; : 167 doi: 10.1007/978-3-030-50983-5_9
|
| 41 |
Anna Karin Belfrage, Eldar Abdurakhmanov, Eva Åkerblom, Peter Brandt, Hiba Alogheli, Johan Neyts, U. Helena Danielson, Anja Sandström. Pan-NS3 protease inhibitors of hepatitis C virus based on an R3-elongated pyrazinone scaffold. European Journal of Medicinal Chemistry 2018; 148: 453 doi: 10.1016/j.ejmech.2018.02.032
|
| 42 |
Graham R. Foster, Kazuaki Chayama, Wan-Long Chuang, Hugo Fainboim, Martti Farkkila, Adrian Gadano, Giovanni B. Gaeta, Christophe Hézode, Yukiko Inada, Jeong Heo, Hiromitsu Kumada, Sheng-Nan Lu, Patrick Marcellin, Christophe Moreno, Stuart K. Roberts, Simone I. Strasser, Alexander J. Thompson, Joji Toyota, Seung Woon Paik, John M. Vierling, Anna L. Zignego, David Cohen, Fiona McPhee, Megan Wind-Rotolo, Subasree Srinivasan, Matthew Hruska, Heather Myler, Simon D. Portsmouth. A randomized, controlled study of peginterferon lambda-1a/ribavirin ± daclatasvir for hepatitis C virus genotype 2 or 3. SpringerPlus 2016; 5(1) doi: 10.1186/s40064-016-2920-z
|
| 43 |
Ying Wang, Bairong Shen. Translational Informatics. Advances in Experimental Medicine and Biology 2022; 1368: 21 doi: 10.1007/978-981-16-8969-7_2
|
| 44 |
Bart Fevery, Simone Susser, Oliver Lenz, Gavin Cloherty, Dany Perner, Leen Gilles, Patrick De Locht, Gaston Picchio, Sandra De Meyer, Christoph Sarrazin. Comparison of three quantitative HCV RNA assays in samples from HCV genotype 1- or 4-infected patients treated with the NS3/4A protease inhibitor simeprevir. Journal of Clinical Virology 2015; 72: 133 doi: 10.1016/j.jcv.2015.09.015
|
| 45 |
Sofija Sekulic, Zeljko Mijailovic, Dejan Petrovic, Ruzica Lukic, Marina Jovanovic, Ivan Jovanovic. HCV Infection and Chronic Renal Disease. Serbian Journal of Experimental and Clinical Research 2021; 0(0) doi: 10.2478/sjecr-2021-0010
|
| 46 |
Melanie Mallory, David Hillyard. Clinical Virology Manual. 2016; : 351 doi: 10.1128/9781555819156.ch25
|
| 47 |
Hsu-Heng Yen, Pei-Yuan Su, Ya-Huei Zeng, I-Ling Liu, Siou-Ping Huang, Yu-Chun Hsu, Yang-Yuan Chen, Chia-Wei Yang, Shun-Sheng Wu, Kun-Ching Chou, Tatsuo Kanda. Glecaprevir–pibrentasvir for chronic hepatitis C: Comparing treatment effect in patients with and without end-stage renal disease in a real-world setting. PLOS ONE 2020; 15(8): e0237582 doi: 10.1371/journal.pone.0237582
|
| 48 |
Mansun Law. Antibody Responses in Hepatitis C Infection. Cold Spring Harbor Perspectives in Medicine 2021; 11(3): a036962 doi: 10.1101/cshperspect.a036962
|
| 49 |
Tse-Ling Fong, Brian T. Lee, Mimi Chang, Khishigsuren Nasanbayar, Enkhjargal Tsogtoo, Delgerbat Boldbaatar, Esugen D. Dashdorj, Namuun E. Clifford, Arghun N. Dashdorj, Bo-Ram Bang, Takeshi Chida, Carolina Lim, Masaya Sugiyama, Masashi Mizokami, Naranjargal J. Dashdorj, Ping Liu, Jeffrey S. Glenn, Naranbaatar D. Dashdorj, Takeshi Saito. High Prevalence of Chronic Viral Hepatitis and Liver Fibrosis Among Mongols in Southern California. Digestive Diseases and Sciences 2021; 66(8): 2833 doi: 10.1007/s10620-020-06499-6
|
| 50 |
Arnolfo Petruzziello, Giovanna Loquercio, Rocco Sabatino, Daniel Vasile Balaban, Najeeb Ullah Khan, Mauro Piccirillo, Luis Rodrigo, Lucia di Capua, Annunziata Guzzo, Francesco Labonia, Gerardo Botti. Prevalence of Hepatitis C virus genotypes in nine selected European countries: A systematic review. Journal of Clinical Laboratory Analysis 2019; 33(5) doi: 10.1002/jcla.22876
|
| 51 |
Yao Wang, Zeyu Zhao, Hao Zhang, Qin Lin, Ning Wang, Mikah Ngwanguong Hannah, Jia Rui, Tianlong Yang, Peihua Li, Siying Mao, Shengnan Lin, Xingchun Liu, Yuanzhao Zhu, Jingwen Xu, Meng Yang, Li Luo, Chan Liu, Zhuoyang Li, Bin Deng, Jiefeng Huang, Weikang Liu, Benhua Zhao, Yanhua Su, Tianmu Chen. Estimating the transmissibility of hepatitis C: A modelling study in Yichang City, China. Journal of Viral Hepatitis 2021; 28(10): 1464 doi: 10.1111/jvh.13582
|
| 52 |
Sirio Fiorino, Fabio Tateo, Dario De Biase, Claudio G Gallo, Paolo E Orlandi, Ivan Corazza, Roberta Budriesi, Matteo Micucci, Michela Visani, Elisabetta Loggi, Wandong Hong, Roberta Pica, Federico Lari, Maddalena Zippi. Sars-CoV-2: Lessons from Both the History of Medicine and from the Biological Behavior of Other Well-Known Viruses. Future Microbiology 2021; 16(14): 1105 doi: 10.2217/fmb-2021-0064
|
| 53 |
Aaditya Chandrasekar, Brynn Chavira, Varun Kesar, Thomas Joseph, Marrieth Rubio, Anita Kablinger. Hepatitis C screening, education, and linkage to care in an acute adult inpatient psychiatric unit. General Hospital Psychiatry 2020; 67: 165 doi: 10.1016/j.genhosppsych.2020.06.004
|
| 54 |
Momen Askoura, Hisham A. Abbas, Hadeel Al Sadoun, Wesam H. Abdulaal, Amr S. Abu Lila, Khaled Almansour, Farhan Alshammari, El-Sayed Khafagy, Tarek S. Ibrahim, Wael A. H. Hegazy. Elevated Levels of IL-33, IL-17 and IL-25 Indicate the Progression from Chronicity to Hepatocellular Carcinoma in Hepatitis C Virus Patients. Pathogens 2022; 11(1): 57 doi: 10.3390/pathogens11010057
|
| 55 |
Pramod B. Mahajan. Recent Advances in Application of Pharmacogenomics for Biotherapeutics. The AAPS Journal 2016; 18(3): 605 doi: 10.1208/s12248-016-9903-4
|
| 56 |
Ruixue Wang, Saori Suzuki, Johnathan D. Guest, Brigitte Heller, Maricar Almeda, Alexander K. Andrianov, Alexander Marin, Roy A. Mariuzza, Zhen-Yong Keck, Steven K. H. Foung, Abdul S. Yunus, Brian G. Pierce, Eric A. Toth, Alexander Ploss, Thomas R. Fuerst. Induction of broadly neutralizing antibodies using a secreted form of the hepatitis C virus E1E2 heterodimer as a vaccine candidate. Proceedings of the National Academy of Sciences 2022; 119(11) doi: 10.1073/pnas.2112008119
|
| 57 |
Trudy M. Wassenaar, Se‐Ran Jun, Michael Robeson, David W. Ussery. Comparative genomics of hepatitis A virus, hepatitis C virus, and hepatitis E virus provides insights into the evolutionary history of Hepatovirus species. MicrobiologyOpen 2020; 9(2) doi: 10.1002/mbo3.973
|
| 58 |
Vladimir Kartashev, Matthias Döring, Leonardo Nieto, Eleda Coletta, Rolf Kaiser, Saleta Sierra, A. Guerrero, H. Stoiber, C. Paar, A.M. Vandamme, F. Nevens, M. Van Ranst, L. Cuypers, P. Braun, R. Ehret, M. Obermeier, S. Schneeweiss, S. Scholten, K. Römer, K. Isernhagen, N. Qurashi, E. Heger, E. Knops, M. Neumann-Fraune, J. Timm, A. Walker, N. Lübke, H. Wedemeyer, J. Schulze zur Wiesch, M. Lütgehetmann, S. Polywka, M. Däumer, D. Hoffmann, U. Protzer, N. Marascio, A. Foca, M.C. Liberto, G.S. Barreca, L. Galati, C. Torti, V. Pisani, C.F. Perno, F. Ceccherini-Silberstein, V. Cento, M. Ciotti, M. Zazzi, B. Rossetti, A.De Luca, C. Caudai, O. Mor, C. Devaux, T. Staub, F. Araujo, P. Gomes, J. Cabanas, N. Markin, I. Khomenko, M. Govorukhina, G. Lugovskaya, D. Dontsov, A. Mas, E. Martró, V. Saludes, F. Rodríguez-Frías, F. García, P. Casas, A. de la Iglesia, J.C. Alados, M.J. Pena-López, M.J. Rodríguez, J.C. Galán, A. Suárez, L. Cardeñoso, M.D. Guerrero, C. Vegas-Dominguez, J. Blas-Espada, R. García, S. García-Bujalance, L. Benítez-Gutiérrez, C. de Mendoza, N. Montiel, J. Santos, I. Viciana, A. Delgado, P.A. Martínez-Sanchez, M. Fernández-Alonso, G. Reina, M. Trigo, M.J. Echeverría, A. Aguilera, D. Navarro, S. Bernal, M.C. Lozano, F. Fernández-Cuenca, A. Orduña, J.M. Eiros, R. Ortíz de Lejarazu, A.M. Martínez-Sapiña, A. García-Díaz, T. Haque. New findings in HCV genotype distribution in selected West European, Russian and Israeli regions. Journal of Clinical Virology 2016; 81: 82 doi: 10.1016/j.jcv.2016.05.010
|
| 59 |
Martina Smolić, Tea Omanović, Ivana Božić, Ines Bilić-Ćurčić, Robert Smolić, Aleksandar Včev. Update on Hepatitis C. 2017; doi: 10.5772/intechopen.70794
|
| 60 |
Virginia Sedeño-Monge, Saul Laguna-Meraz, Gerardo Santos-López, Arturo Panduro, Francisca Sosa-Jurado, Alexis Jose-Abrego, Daniel Meléndez-Mena, Marco A. Muñoz-Ramírez, Monserrat Cosme-Chávez, Sonia Roman. A comprehensive update of the status of hepatitis C virus (HCV) infection in Mexico—A systematic review and meta-analysis (2008–2019). Annals of Hepatology 2021; 20: 100292 doi: 10.1016/j.aohep.2020.100292
|
| 61 |
Hui-Chun Li, Chee-Hing Yang, Shih-Yen Lo. Cellular factors involved in the hepatitis C virus life cycle. World Journal of Gastroenterology 2021; 27(28): 4555-4581 doi: 10.3748/wjg.v27.i28.4555
|
| 62 |
Raoul Blindenbacher, Bettina Maeschli, Philip Bruggmann. The Swiss Hepatitis Strategy as a model for facing future health policy challenges. Health Policy 2019; 123(7): 681 doi: 10.1016/j.healthpol.2019.05.010
|
| 63 |
Hsu-Heng Yen, Pei-Yuan Su, I-Ling Liu, Ya-Yuei Zeng, Siou-Ping Huang, Yu-Chun Hsu, Chia-Wei Yang, Yang-Yuan Chen. Direct-acting antiviral treatment for Hepatitis C Virus in geriatric patients: a real-world retrospective comparison between early and late elderly patients. PeerJ 2021; 9: e10944 doi: 10.7717/peerj.10944
|
| 64 |
Sara Abouelasrar Salama, Mieke Gouwy, Alexandra De Zutter, Noëmie Pörtner, Lotte Vanbrabant, Nele Berghmans, Mieke De Buck, Sofie Struyf, Jo Van Damme. Induction of Chemokines by Hepatitis C Virus Proteins: Synergy of the Core Protein with Interleukin-1β and Interferon-γ in Liver Bystander Cells. Journal of Interferon & Cytokine Research 2020; 40(4): 195 doi: 10.1089/jir.2019.0115
|
| 65 |
Daniel Ferguson, Jun Zhang, Matthew A. Davis, Robert N. Helsley, Lise-Lotte Vedin, Richard G. Lee, Rosanne M. Crooke, Mark J. Graham, Daniela S. Allende, Paolo Parini, J.Mark Brown. The lipid droplet-associated protein perilipin 3 facilitates hepatitis C virus-driven hepatic steatosis. Journal of Lipid Research 2017; 58(2): 420 doi: 10.1194/jlr.M073734
|
| 66 |
Amjad Khan, Abdul Nadir, Muhammad Hassan Mushtaq, Khunsa Junaid, Aabish Mehreen Khan, Hassan Ali, Fatmee Waqar, Taimoor Akram Khan, Ali Akram Khan. Molecular epidemiology and genotype distribution of hepatitis C in Pakistan; a multicenter cross-sectional study. Infection, Genetics and Evolution 2020; 84: 104372 doi: 10.1016/j.meegid.2020.104372
|
| 67 |
Iryna V. Balaniuk, Elena V. Myronyk, Yuriy O. Randiuk, Аndriy V. Andruschak. GENERAL IMMUNOLOGICAL REACTIVITY OF PATIENT’S ORGANISM WITH CHRONIC HEPATITIS С. Wiadomości Lekarskie 2019; 72(7): 1310 doi: 10.36740/WLek201907115
|
| 68 |
Leena Chularojanamontri, Supot Nimanong, Chanisada Wongpraparut, Narumol Silpa-Archa, Chayada Chaiyabutr, Norramon Charoenpipatsin. How do we treat psoriasis patients with hepatitis C infections in real-world situations? A retrospective analysis of 34 patients. Journal of Dermatological Treatment 2021; 32(3): 321 doi: 10.1080/09546634.2019.1657225
|
| 69 |
Kavita N. Thakur, Nirankush Borah, Shweta Gangurde, Hetal Rathod. Mutation in RNA Viruses: A Challenge to Effective Vaccine Development. Medical Journal of Dr. D.Y. Patil Vidyapeeth 2023; 16(Suppl 1): S170 doi: 10.4103/mjdrdypu.mjdrdypu_315_22
|
| 70 |
Navroop Nagra, Richard A. Kozarek, Blaire E. Burman. Therapeutic Advances in Viral Hepatitis A–E. Advances in Therapy 2022; 39(4): 1524 doi: 10.1007/s12325-022-02070-z
|
| 71 |
Tamer A. Hafez. Hepatitis C in Developing Countries. 2018; : 25 doi: 10.1016/B978-0-12-803233-6.00003-5
|
| 72 |
Khayriyyah Mohd Hanafiah, Mary L. Garcia, Nadine C. Barnes, David A. Anderson. Detection of virus-specific polymeric immunoglobulin A in acute hepatitis A, C, E virus serum samples using novel chimeric secretory component. BMC Research Notes 2018; 11(1) doi: 10.1186/s13104-018-3799-2
|
| 73 |
Isabela S. Oliveira, Lucas P. Carvalho, Maria Isabel Schinoni, Raymundo Paraná, Ajax M. Atta, Maria Luiza B. Sousa Atta. Peripheral lymphocyte subsets in chronic hepatitis C: Effects of 12 weeks of antiviral treatment with interferon-alpha plus ribavirin. Microbial Pathogenesis 2016; 91: 155 doi: 10.1016/j.micpath.2015.12.007
|
| 74 |
Winifred Nyinoh Iveren. Genotypic variation, demographic characteristics and risk factors of hepatitis C virus in Scotland. Journal of Public Health and Epidemiology 2018; 10(7): 241 doi: 10.5897/JPHE2018.1031
|
| 75 |
Patrick R. Brown, Omar Sadiq, Alexander Weick, Adrienne Lenhart, Mohammad Elbatta, Christopher Fernandez, Anas Kutait, Robert Pompa, Syed‐Mohammed Jafri. Acute Kidney Injury in Patients Undergoing Chronic Hepatitis C Virus Treatment With Ledipasvir/Sofosbuvir. Hepatology Communications 2018; 2(10): 1172 doi: 10.1002/hep4.1243
|
| 76 |
F. De Conto, M. C. Medici, F. Ferraglia, F. Pinardi, A. Fazzi, M. C. Arcangeletti, C. Chezzi, A. Calderaro. Temporal dynamics of hepatitis C genotypes in a five-year hospital-based surveillance in Northern Italy. Archives of Virology 2016; 161(10): 2727 doi: 10.1007/s00705-016-2975-8
|
| 77 |
Gary Brook, Sanjay Bhagani, Ranjababu Kulasegaram, Adele Torkington, David Mutimer, Elizabeth Hodges, Louise Hesketh, Simon Farnworth, Verity Sullivan, Charles Gore, Emma Devitt, Ann K Sullivan. United Kingdom National Guideline on the Management of the viral hepatitides A, B and C 2015. International Journal of STD & AIDS 2016; 27(7): 501 doi: 10.1177/0956462415624250
|
| 78 |
Kittiyod Poovorawan, Wirichada Pan-ngum, Lisa J. White, Ngamphol Soonthornworasiri, Polrat Wilairatana, Rujipat Wasitthankasem, Pisit Tangkijvanich, Yong Poovorawan, Jason Grebely. Estimating the Impact of Expanding Treatment Coverage and Allocation Strategies for Chronic Hepatitis C in a Direct Antiviral Agent Era. PLOS ONE 2016; 11(9): e0163095 doi: 10.1371/journal.pone.0163095
|
| 79 |
Marcos Galasso, Jordan J. Feld, Yui Watanabe, Mauricio Pipkin, Cara Summers, Aadil Ali, Robert Qaqish, Manyin Chen, Rafaela V. P. Ribeiro, Khaled Ramadan, Layla Pires, Vanderlei S. Bagnato, Cristina Kurachi, Vera Cherepanov, Gray Moonen, Anajara Gazzalle, Thomas K. Waddell, Mingyao Liu, Shaf Keshavjee, Brian C. Wilson, Atul Humar, Marcelo Cypel. Inactivating hepatitis C virus in donor lungs using light therapies during normothermic ex vivo lung perfusion. Nature Communications 2019; 10(1) doi: 10.1038/s41467-018-08261-z
|
| 80 |
Francesco Caso, Luca Cantarini, Filomena Morisco, Antonio Del Puente, Roberta Ramonda, Ugo Fiocco, Ennio Lubrano, Rosario Peluso, Paolo Caso, Mauro Galeazzi, Leonardo Punzi, Raffaele Scarpa, Luisa Costa. Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection. Expert Opinion on Biological Therapy 2015; 15(5): 641 doi: 10.1517/14712598.2015.1011616
|
| 81 |
Gary Brook, Norbert Brockmeyer, Thijs van de Laar, Sven Schellberg, Andrew J Winter. 2017 European guideline for the screening, prevention and initial management of hepatitis B and C infections in sexual health settings. International Journal of STD & AIDS 2018; 29(10): 949 doi: 10.1177/0956462418767576
|
| 82 |
Santiago Sánchez-Pardo, Andrés Ochoa-Díaz, Jhon E Prieto-Ortiz. Alteraciones Hepaticas en pacientes con infección por VIH en un centro de investigacion en Bogotá Colombia 2009 – 2019. Infectio 2021; 25(4): 250 doi: 10.22354/in.v25i4.956
|
| 83 |
Beatriz Torres-Vázquez, Ana María de Lucas, Carlos García-Crespo, Juan Antonio García-Martín, Adrián Fragoso, María Fernández-Algar, Celia Perales, Esteban Domingo, Miguel Moreno, Carlos Briones. In vitro Selection of High Affinity DNA and RNA Aptamers that Detect Hepatitis C Virus Core Protein of Genotypes 1 to 4 and Inhibit Virus Production in Cell Culture. Journal of Molecular Biology 2022; 434(7): 167501 doi: 10.1016/j.jmb.2022.167501
|
| 84 |
Ronaldo Luis Thomasini, Hortencia Gisele Amaro Souza, Oscar Bruna‐Romero, Antonio Helvecio Totola, Neiva Sellan Lopes Gonçales, Cristiano Xavier Lima, Mauro Martins Teixeira. Evaluation of a recombinant multiepitope antigen for diagnosis of hepatitis C virus: A lower cost alternative for antigen production. Journal of Clinical Laboratory Analysis 2018; 32(6) doi: 10.1002/jcla.22410
|
| 85 |
Jeffrey V. Lazarus, Elena Roel, Ahmed M. Elsharkawy. Hepatitis C Virus Epidemiology and the Impact of Interferon-Free Hepatitis C Virus Therapy. Cold Spring Harbor Perspectives in Medicine 2020; 10(3): a036913 doi: 10.1101/cshperspect.a036913
|
| 86 |
Hilla Knobler, Stephen Malnick. Hepatitis C and insulin action: An intimate relationship. World Journal of Hepatology 2016; 8(2): 131-138 doi: 10.4254/wjh.v8.i2.131
|
| 87 |
Rodolfo Castro, Hugo Perazzo, Beatriz Grinsztejn, Valdilea G. Veloso, Chris Hyde. Chronic Hepatitis C: An Overview of Evidence on Epidemiology and Management from a Brazilian Perspective. International Journal of Hepatology 2015; 2015: 1 doi: 10.1155/2015/852968
|
| 88 |
Quratulain Maqsood, Maria Hussain, Aleena Sumrin. Hepatitis C - Recent Advances. 2023; doi: 10.5772/intechopen.1001050
|
| 89 |
Sara Abouelasrar Salama, Muriel Lavie, Mieke De Buck, Jo Van Damme, Sofie Struyf. Cytokines and serum amyloid A in the pathogenesis of hepatitis C virus infection. Cytokine & Growth Factor Reviews 2019; 50: 29 doi: 10.1016/j.cytogfr.2019.10.006
|
| 90 |
G.S. Pancar, T. Kaynar. Nailfold capillaroscopic changes in patients with chronic viral hepatitis. Microvascular Research 2020; 129: 103970 doi: 10.1016/j.mvr.2019.103970
|
| 91 |
|
| 92 |
Vigneswaran Narayanamurthy, Z. E. Jeroish, K. S. Bhuvaneshwari, Fahmi Samsuri. Hepatitis C virus (HCV) diagnosis via microfluidics. Analytical Methods 2021; 13(6): 740 doi: 10.1039/D0AY02045A
|
| 93 |
|
| 94 |
A.A. Khryanin, A.V. Sokolovskaia, V.K. Bocharova. Lichen planus associated with viral hepatitis C: new data, concepts and hypotheses. Klinicheskaya dermatologiya i venerologiya 2023; 22(4): 426 doi: 10.17116/klinderma202322041426
|
| 95 |
A. Ferreira-Gonzalez. Diagnostic Molecular Pathology. 2017; : 485 doi: 10.1016/B978-0-12-800886-7.00038-8
|
| 96 |
Valeriu Harabor, Raluca Mogos, Aurel Nechita, Ana-Maria Adam, Gigi Adam, Alina-Sinziana Melinte-Popescu, Marian Melinte-Popescu, Mariana Stuparu-Cretu, Ingrid-Andrada Vasilache, Elena Mihalceanu, Alexandru Carauleanu, Anca Bivoleanu, Anamaria Harabor. Machine Learning Approaches for the Prediction of Hepatitis B and C Seropositivity. International Journal of Environmental Research and Public Health 2023; 20(3): 2380 doi: 10.3390/ijerph20032380
|
| 97 |
Victoria Belousova, Ahmed A. Abd-Rabou, Shaker A. Mousa. Recent advances and future directions in the management of hepatitis C infections. Pharmacology & Therapeutics 2015; 145: 92 doi: 10.1016/j.pharmthera.2014.09.002
|
| 98 |
Guglielmo Borgia, Riccardo Scotto, Antonio Riccardo Buonomo. An update on recent developments in the search for hepatitis C virus therapies with pan-genotypic efficacy. Expert Opinion on Investigational Drugs 2019; 28(5): 395 doi: 10.1080/13543784.2019.1602766
|
| 99 |
Nadia A. Nabulsi, Michelle T. Martin, Lisa K. Sharp, David E. Koren, Robyn Teply, Autumn Zuckerman, Todd A. Lee. Predicting Treatment Failure for Initiators of Hepatitis C Virus Treatment in the era of Direct-Acting Antiviral Therapy. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.551500
|
| 100 |
Ս․Ռ․ Սարգսյան. ՔՐՈՆԻԿ ՎԻՐՈՒՍԱՅԻՆ C ՀԵՊԱՏԻՏ. ՀԱԿԱՎԻՐՈՒՍԱՅԻՆ ԲՈՒԺՄԱՆ ՓՈՒԼԵՐԸ (ՎԵՐԼՈՒԾՈՒԹՅՈՒՆ). MEDICINE, SCIENCE AND EDUCATION 2022; (33): 22 doi: 10.56936/18291775-2022.33-22
|
| 101 |
Manish Dwivedi, Aditya Dwivedi, Debalina Mukherjee. An Insight into Hepatitis C Virus: In Search of Promising Drug Targets. Current Drug Targets 2023; 24(14): 1127 doi: 10.2174/0113894501265769231020031857
|
| 102 |
Daire O'Shea, John Law, Adrian Egli, Donna Douglas, Gary Lund, Sarah Forester, Joshua Lambert, Mansun Law, Dennis R. Burton, D. L. J. Tyrrell, Michael Houghton, Atul Humar, Norman Kneteman. Prevention of hepatitis C virus infection using a broad cross‐neutralizing monoclonal antibody (AR4A) and epigallocatechin gallate. Liver Transplantation 2016; 22(3): 324 doi: 10.1002/lt.24344
|
| 103 |
A. Aguilera, D. Navarro, F. Rodríguez‐Frias, I. Viciana, A. M. Martínez‐Sapiña, M. J. Rodríguez, E. Martró, M. C. Lozano, E. Coletta, L. Cardeñoso, A. Suárez, M. Trigo, J. Rodríguez‐Granjer, N. Montiel, A. de la Iglesia, J. C. Alados, C. Vegas, S. Bernal, F. Fernández‐Cuenca, M. J. Pena, G. Reina, S. García‐Bujalance, M. J. Echevarria, L. Benítez, S. Pérez‐Castro, D. Ocete, I. García‐Arata, C. Guerrero, M. Rodríguez‐Iglesias, P. Casas, F. García. Prevalence and distribution of hepatitis C virus genotypes in Spain during the 2000‐2015 period (the GEHEP 005 study). Journal of Viral Hepatitis 2017; 24(9): 725 doi: 10.1111/jvh.12700
|
| 104 |
Jing Peng, Yanjun Lu, Weiyong Liu, Yaowu Zhu, Xiaoling Yan, Jingxin Xu, Xiong Wang, Yue Wang, Wei Liu, Ziyong Sun, Yury E Khudyakov. Genotype Distribution and Molecular Epidemiology of Hepatitis C Virus in Hubei, Central China. PLOS ONE 2015; 10(9): e0137059 doi: 10.1371/journal.pone.0137059
|
| 105 |
Petra Surlin, Dorin Nicolae Gheorghe, Liliana Foia, Amelia Surdu, Vasilica Toma, Sorina Mihaela Solomon, Dan Nicolae Florescu, Ion Rogoveanu. Hepatitis C - From Infection to Cure. 2018; doi: 10.5772/intechopen.76135
|
| 106 |
Basim M. Ali, Furqan Moein, Maha Al-Andaleb, Shaymaa Dhyaa. A field study dealing with biocmetrics of some clinical variables for hepatitis C patients. Al-Kufa University Journal for Biology 2021; 13(2): 32 doi: 10.36320/ajb/v13.i2.11757
|
| 107 |
Arnolfo Petruzziello, Samantha Marigliano, Giovanna Loquercio, Carmela Cacciapuoti. Hepatitis C virus (HCV) genotypes distribution: an epidemiological up-date in Europe. Infectious Agents and Cancer 2016; 11(1) doi: 10.1186/s13027-016-0099-0
|
| 108 |
Ning Zhao, Wei Zheng, Dan Wu, Xuelian Wang, Wei Yang, Lin Yuan, Zhiqiang Niu, Xiaodi Jiang, Fen Huang, Zhiwei Li. Clinical value of hepatitis C virus core antigen levels in monitoring acute hepatitis C spontaneous clearance or treatment‐induced clearance. Journal of Medical Virology 2018; 90(12): 1787 doi: 10.1002/jmv.25256
|
| 109 |
Alexios Chatzigoulas, Zoe Cournia. Rational design of allosteric modulators: Challenges and successes. WIREs Computational Molecular Science 2021; 11(6) doi: 10.1002/wcms.1529
|
| 110 |
Harita Nyalakonda, Netanya S. Utay. A new era of therapy for hepatitis C virus infection. Current Opinion in Infectious Diseases 2015; 28(5): 471 doi: 10.1097/QCO.0000000000000190
|
| 111 |
Yutaka Kawano, Koji Miyanishi, Satoshi Takahashi, Tomohiro Kubo, Kazuma Ishikawa, Shintaro Sugita, Kohichi Takada, Masayoshi Kobune, Tadashi Hasegawa, Junji Kato. Hepatitis C virus reactivation due to antiemetic steroid therapy during treatment of hepatocellular carcinoma. Journal of Infection and Chemotherapy 2017; 23(5): 323 doi: 10.1016/j.jiac.2016.12.008
|
| 112 |
Yanli Bai, Yanrong Zhou, Huabing Liu, Liurong Fang, Jiangong Liang, Shaobo Xiao. Glutathione-Stabilized Fluorescent Gold Nanoclusters Vary in Their Influences on the Proliferation of Pseudorabies Virus and Porcine Reproductive and Respiratory Syndrome Virus. ACS Applied Nano Materials 2018; 1(2): 969 doi: 10.1021/acsanm.7b00386
|
| 113 |
Vijay Gayam, Arshpal Gill, Pavani Garlapati, Smruti Mohanty. Hepatitis B and C. 2020; doi: 10.5772/intechopen.83609
|
| 114 |
Ruirui Chang, Si-Tao Xu, Hao-Wen Jin, Yong-Jie Zhao, Tian-Yu Hu, Guangji Wang, Jiankun Wang, Le Zhen. Simultaneous determination of ZL-01, a novel nucleotide prodrug, and its metabolites in rat plasma by LC-MS/MS: Application to pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis 2022; 208: 114437 doi: 10.1016/j.jpba.2021.114437
|
| 115 |
Mathilde Bourdon, Alicia Garnier, Chloé Maignien, Louis Marcellin, Emmanuel Dulioust, Philippe Sogni, Odile Launay, Khaled Pocate Cheriet, Catherine Patrat, Charles Chapron, Pietro Santulli. Assisted reproductive technology outcomes in women with a chronic viral disease. AIDS 2021; 35(7): 1073 doi: 10.1097/QAD.0000000000002859
|
| 116 |
Bianca Heinrich, John P. Bilello. Antimicrobial Drug Resistance. 2017; : 579 doi: 10.1007/978-3-319-46718-4_39
|
| 117 |
Abolghasem Asadi-Saghandi, Ali Shams, Gilda Eslami, Seyed Ali Mirghanizadeh, Ebrahim Eskandari-Nasab. Peginterferon Alfa-2a/Ribavirin treatment efficacy in chronic hepatitis C patients is related to natural killer group 2D gene rs1049174 GC polymorphism. VirusDisease 2016; 27(4): 369 doi: 10.1007/s13337-016-0349-1
|